We are live on ! Find out more
ATRC icon

AtriCure

114 hedge funds and large institutions have $664M invested in AtriCure in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 23

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

7% more funds holding

Funds holding: 107114 (+7)

3.51% more ownership

Funds ownership: 82.99%86.49% (+3.5%)

3% less capital invested

Capital invested by funds: $683M → $664M (-$19M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $369K

Holders
114
Holders Change
+7
Holders Change %
+6.54%
% of All Funds
2.84%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
19
Increased
45
Reduced
23
Closed
12
Calls
Puts
$369K
Net Calls
-$369K
Net Calls Change
-$262K
Name Holding Trade Value Shares
Change
Change in
Stake
GT
126
Glenmede Trust
Pennsylvania
-$1K -85 Closed

ATRC Hedge Fund Activity: Q3 2017 in Review

114 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2017, worth a combined $664M — down 2.8% from $683M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ATRC positions and 12 closed out — a net gain of 7 holders — while 45 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $39.3M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $69.1M sold.

  • 114 institutional investors held AtriCure (ATRC) as of Q3 2017, up from 107 in Q2 2017.
  • Funds reported $664M of AtriCure stock for Q3 2017, down 2.8% quarter-over-quarter.
  • 19 funds opened new AtriCure positions in Q3 2017 and 12 closed out, a net change of +7 holders.
  • The largest AtriCure buyer in Q3 2017 was Wellington Management Group, an estimated $39.3M added.
  • The largest AtriCure seller in Q3 2017 was Consonance Capital Management, an estimated $69.1M sold.

Based on aggregated 13F filings for Q3 2017.